DRMA: Dermata Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-11-02 | New 13G stake | BIGGER CAPITAL FUND L P | 8.36% | SEC |
Institutional ownership (Q2 2026)
13 institutions reported holding $158K of Dermata Therapeutics, Inc. on Form 13F (7 the quarter before). 7 opened a new position and 1 sold out. Shares held by institutions: +15%.
| Largest holders | Shares | Value |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 20,203 | $26K |
| Welch & Forbes LLC | 20,000 | $26K |
| STATE STREET CORP | 18,747 | $24K |
| UBS Group AG | 16,796 | $22K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,989 | $21K |
| XTX Topco Ltd | 14,787 | $19K |
| Advisory Alpha, LLC | 10,000 | $13K |
| Tower Research Capital LLC (TRC) | 3,860 | $5K |
| MCF Advisors LLC | 1,732 | $2K |
| BARCLAYS PLC | 270 | $348 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.